Neuronetics (STIM) Net Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 708.00 |
| Dec 31, 2025 | 3,977.00 |
| Sep 30, 2025 | 2,480.00 |
| Jun 30, 2025 | 3,743.00 |
| Mar 31, 2025 | 1,010.00 |
| Dec 31, 2024 | -2,794.00 |
| Sep 30, 2024 | 588.00 |
| Jun 30, 2024 | -1,551.00 |
| Mar 31, 2024 | 2,097.00 |
| Dec 31, 2023 | 1,763.00 |
| Sep 30, 2023 | -559.00 |
| Jun 30, 2023 | 1,666.00 |
| Mar 31, 2023 | 754.00 |
| Dec 31, 2022 | 457.00 |
| Sep 30, 2022 | 861.00 |
| Jun 30, 2022 | -1,180.00 |
| Mar 31, 2022 | -1,412.00 |
| Dec 31, 2021 | -2,951.00 |
| Sep 30, 2021 | -3,172.00 |
| Jun 30, 2021 | 2,744.00 |
| Mar 31, 2021 | 3,829.00 |
| Dec 31, 2020 | 2,163.00 |
| Sep 30, 2020 | 1,784.00 |
| Jun 30, 2020 | -3,505.00 |
| Mar 31, 2020 | -3,987.00 |
| Dec 31, 2019 | -298.00 |
| Sep 30, 2019 | -707.00 |
| Jun 30, 2019 | 82.00 |
| Mar 31, 2019 | -822.00 |
| Dec 31, 2018 | -114.00 |
| Sep 30, 2018 | -381.00 |
| Jun 30, 2018 | -1,440.00 |
| Mar 31, 2018 | 587.00 |